JPM: Is the UK's clinical trials sector turning a corner?

JPM: Is the UK's clinical trials sector turning a corner?

New data from the UK medicines regulator has shown an increase in clinical trial activity in the country, after years of decline

Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation

The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments more quickly and boosting the UK's competitiveness for global clinical research. The UK is ramping up efforts to become a global first choice for clinical trials, as new figures published today (13 January 2026), show a sharp rise in activity in 2025, and changes coming this year - including a fast-track route – that will …